• Mon. Jun 5th, 2023

Celyad Oncology provides an update on its strategic business model, continuing to focus on opportunities to fully harness the true potential of its proprietary technology platforms and intellectual property


Dec 21, 2022
Celyad Oncology, a biotechnology company focused on the discovery and development of innovative technologies for chimeric antigen receptor T-cell therapies, provides an update on its Celyad 2.0 business strategy which has been adopted and implemented over the last few months.

Read More